TenX Keane Acquisition(TENK) - 2025 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-41534 Citius Oncology, Inc. (Exact name of Registrant as specified in its Charter) | Delaware | 99-4362660 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | ...